Alexion, Pfizer sign $1 billion accord for genomic medicines
HQ Team July 29, 2023: Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for.
Drugs
Health
Pharma
Drugs
Health
Pharma
FDA’s advisory panel backs Sanofi, AstraZeneca’s investigational drug for newborns
HQ Team June 9, 2023: An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug.
Drugs
Health
Pharma
AstraZeneca signs $2 billion deal for autoimmune diseases
HQ Team June 9, 2023: AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to.
Drugs
Health
Pharma
Canada’s Fusion gets FDA nod for drug tests to treat solid tumors
HQ Team April 13, 2023: Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid.
Drugs
Pharma
Glenmark gets 2nd FDA nod for high blood sugar drug
Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.
Drugs
Pharma
AstraZeneca to acquire US-based CinCor for $1.8 billion
AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.
